A new trend in product introduction matches technical needs with technical solutions from external sources.

Respondents to our first salary and budget survey answered questions on the workplace, money, and job satisfaction.

Bio-Matrix Scientific Group Inc., a biotechnology company focused on stem cell cryogenics and disposable stem cell / tissue transfer instruments said it progress on its planned 15,000 square foot Stem Cell Bank and Laboratories has

Zogenix, Inc., a privately held neuroscience-focused specialty pharmaceutical company, announced today it has received $3.5 million of a $10 million loan facility with GE Healthcare Financial Services.

Zogenix wi

Nanosys, Inc. and Bruker Daltonics Inc. today announced that they have entered into a broad R&D collaboration and distribution agreement for Nanosys' nanotechnology-enabled matrix-free target plates for use primarily with Bruker's F

A $33 million donation will help build a home for Stanford's Institute for Stem Cell Biology and Regenerative Medicine.

Lorry I. Lokey, the founder of Business Wire and a supporter of education and science, will

Salix Pharmaceuticals, Ltd. today announced that it has purchased the U.S. prescription pharmaceutical product rights to PEPCID Oral Suspension and DIURIL Oral Suspension from Merck & Co., Inc.

PEPCID Oral Suspens

New England has 42 new facilities scheduled to be completed this year, with a total investment value of $1.2 billion, according to published reports.

When the plants become fully operational an estimated 4,000 job

Athenix Corp. announced it is moving its operations from Durham, N.C. to Research Triangle Park.

Athenix is a biotechnology company that develops products and technologies for agricultural and sustainable industri

A bill that would allocate $25 million toward the creation of a Phoenix Biomedical Campus has passed Arizona's Health Committee unanimously, according to published reports.

Three university presidents, the dean of

Abraxis BioScience, Inc. today announced it has completed the acquisition of the Pfizer Inc. Cruce Dávila manufacturing facility in Barceloneta, Puerto Rico.

The 56-acre site consists of a 172,000 square foot val